Insight Molecular Diagnostics Inc

IMDXNASDAQ · USD
3.92USD0.00 (-0.76%)
137

Insight Molecular Diagnostics Inc (IMDX) Historical Volatility

IMDX 30-day historical volatility is 78%. This ranks in the 23th percentile of readings over the past year.

Read more

Tracking IMDX historical volatility helps you see how much Insight Molecular Diagnostics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Insight Molecular Diagnostics Inc's HV tells you what really happened. Use our scanner to monitor IMDX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The IMDX 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Insight Molecular Diagnostics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.

OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Insight Molecular Diagnostics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where IMDX HV is running hot, cold, or in line. Make the IMDX 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 25, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 25, 2026

See how volatility has moved over time

Track IMDX historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial